GGrantScoutHQCreate alert

Curated topic

Grants for Public Housing Authorities — Page 10

Housing and community opportunities with public or Indian housing authority eligibility.

232 current opportunities · showing 217–232

OPENHealth & Medical

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be effic

Deadline
May 8, 2028
Funding
Estimated total program funding: $1,000,000
Check fit and official source →
OPENResearch & Science

Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)

National Institutes of Health

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in ca

Deadline
May 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)

National Institutes of Health

The purpose of this initiative is to support the development of innovative research centers to foster nursing-led programs that promote community-partnered research to address persistent health challenges. Center applications developed in response to this RFA should propose strategies to strengthen

Deadline
May 8, 2028
Funding
Up to $500,000
Check fit and official source →
OPENHealth & Medical

NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) program is to develop and maintain a strong cohort of independently funded dentist scientists dedicated to improving dental, oral and craniofacial health. This program is designed to facilitate a timely tr

Deadline
May 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications to use NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of Heart, Lung, Blood, and Sleep (HLBS) diso

Deadline
May 9, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)

National Institutes of Health

The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for research on how mind and body interventions through psychological and/or physical inputs (e.g., mindfulness meditation, yoga, acupuncture, massage, and

Deadline
Jun 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling effici

Deadline
Jul 21, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes

Deadline
Aug 22, 2028
Funding
Up to $3,000,000
Check fit and official source →
OPENResearch & Science

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

National Institutes of Health

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must no

Deadline
Aug 26, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

National Institutes of Health

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and inn

Deadline
Sep 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

National Institutes of Health

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and

Deadline
Sep 8, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retro

Deadline
Nov 6, 2028
Funding
Up to $400,000
Check fit and official source →
OPENHealth & Medical

Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit UG3/UH3 phased, cooperative agreement research applications to evaluate, implement, and/or test population-based interventions to policies, programs, and/or practices for promoting integration of services, systems, and/or values

Deadline
Nov 17, 2028
Funding
Up to $300,000
Check fit and official source →
OPENHealth & Medical

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

National Institutes of Health

Current recipients of specific types of NIH research grants may apply for administrative supplements, using this Notice of Funding Opportunity (NOFO), to provide additional funding to a currently funded grant to meet increased costs that are within the scope of the peer-reviewed and approved project

Deadline
Dec 1, 2028
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)

National Institutes of Health

The overall goal of this program is to accelerate scientific discovery, improve research efficiency, and enhance the translation of research findings into improved health outcomes. Centers funded under this program will also foster multidisciplinary collaboration, support workforce development acros

Deadline
Mar 2, 2029
Funding
Estimated total program funding: $17,000,000
Check fit and official source →
OPENHealth & Medical

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HI

Deadline
Jun 21, 2029
Funding
Estimated total program funding: $7,000,000
Check fit and official source →

Strong fit signals

  • Property and resident needs are current
  • Capital and service activities are separated
  • Resident engagement is documented

Requirements to verify

  • Property eligibility
  • Relocation, procurement and environmental rules

How to use this shortlist

Open the official notice for each candidate and build a simple go/no-go table covering legal applicant type, geography, project purpose, award range, match, registrations and submission time zone. Eliminate any program that fails a mandatory condition before spending time on narrative drafting.

Frequently asked questions

Who should use this grants for public housing authorities page?

Public housing and Indian housing authorities. Treat the directory match as a discovery signal and confirm the controlling eligibility language on the funder's notice.

How are opportunities selected?

The page applies a fixed combination of structured applicant, focus, source, award or deadline signals to current directory records. It does not broaden the result with unrelated keywords.

Does a listing mean my organization is eligible?

No. A match helps build a shortlist; the official notice, application package and funder guidance control eligibility and allowable costs.